Europe & Central Asia vs Malta: Tuberculosis treatment success rate
Tuberculosis treatment success rate over time
- Europe & Central Asia
- Malta
How they compare
Malta currently reports 98.0% against 74.0% in Europe & Central Asia, a difference of 24.0%.
That makes Malta's figure about 1.3 times Europe & Central Asia's.
The two have swapped places 6 times across 16 shared years of data; in 2000 it was Malta ahead.
Europe & Central Asia ranks 16th and Malta ranks 14th of 19 groups.
Across the 3 decades both report, Europe & Central Asia averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Europe & Central Asia | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.1% | 87.3% | 12.2% | Malta |
| 2010s | 74.8% | 58.5% | 16.2% | Europe & Central Asia |
| 2020s | 72.0% | 98.5% | 26.5% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Europe & Central Asia or Malta?
- Malta, at 98.0% against 74.0% in Europe & Central Asia as of 2021.
- What is the difference in tuberculosis treatment success rate between Europe & Central Asia and Malta?
- 24.0%, with Malta ahead.
- How many years of comparable data are there for Europe & Central Asia and Malta?
- 16 years are reported by both, from 2000 to 2021.
- How do Europe & Central Asia and Malta rank globally for tuberculosis treatment success rate?
- Europe & Central Asia ranks 16th and Malta ranks 14th of 19 groups.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).